Werewolf Therapeutics, Inc.
NASDAQ:HOWL
1.35 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 110.995 | 134.343 | 129.315 | 157.531 | 92.57 | 17.896 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 110.995 | 134.343 | 129.315 | 157.531 | 92.57 | 17.896 |
| Net Receivables
| 0 | 1.35 | 6.928 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.071 | 2.677 | 3.957 | 3.537 | 0.344 | 0.167 |
| Total Current Assets
| 113.066 | 138.37 | 140.2 | 161.068 | 92.914 | 18.063 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 12.323 | 14.846 | 17.451 | 16.325 | 3.122 | 3.408 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.22 | 21.023 | 1.214 | 1.208 | 0.207 | 0.208 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.32 | 0.594 | 1.38 | 0.649 | 0.155 | 0 |
| Total Non-Current Assets
| 13.863 | 36.463 | 20.045 | 18.182 | 3.484 | 3.616 |
| Total Assets
| 126.929 | 174.833 | 160.245 | 179.25 | 96.398 | 21.679 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3.035 | 1.336 | 1.221 | 2.037 | 1.021 | 0.633 |
| Short Term Debt
| 1.557 | 8.275 | 2.084 | 2.144 | 1.354 | 0.595 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.907 | 6.532 | 0 | 0 | 0 |
| Other Current Liabilities
| 10.588 | 8.86 | 14.152 | 7.693 | 2.909 | 0.816 |
| Total Current Liabilities
| 15.18 | 19.378 | 23.989 | 11.874 | 5.284 | 2.044 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 35.53 | 43.648 | 12.6 | 29.178 | 1.864 | 2.542 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 2.829 | 0.433 | 1.319 | -14.589 | 0.031 | 41.397 |
| Total Non-Current Liabilities
| 38.359 | 44.081 | 13.919 | 14.589 | 1.895 | 43.939 |
| Total Liabilities
| 53.539 | 63.459 | 37.908 | 26.463 | 148.261 | 45.983 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 179.25 | 141.082 | 34.073 |
| Common Stock
| 0.005 | 0.004 | 0.003 | 0.002 | 0.002 | 0.002 |
| Retained Earnings
| -414.588 | -344.073 | -306.705 | -252.895 | -51.865 | -24.408 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -179.25 | -141.084 | -34.073 |
| Other Total Stockholders Equity
| 487.973 | 455.443 | 429.039 | 405.68 | 0.002 | 34.073 |
| Total Shareholders Equity
| 73.39 | 111.374 | 122.337 | 152.787 | -51.863 | -24.304 |
| Total Equity
| 73.39 | 111.374 | 122.337 | 152.787 | -51.863 | -24.304 |
| Total Liabilities & Shareholders Equity
| 126.929 | 174.833 | 160.245 | 179.25 | 96.398 | 21.679 |